DCM
UTHR icon

Davidson Capital Management’s United Therapeutics UTHR Stock Holding History

Davidson Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.94M Buy
10,955
+182
+2% +$103K 0.95% 26
2026
Q1 		$6.39M Buy
10,773
+10,748
+42,992% +$5.35M 1.16% 12
2025
Q4 		$12.2K Buy
+25
New +$11.6K ﹤0.01% 78

Other funds holding UTHR

AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Davidson Capital Management's UTHR Position: Q2 2026 in Review

Davidson Capital Management increased its United Therapeutics (UTHR) stake by 1.7% in Q2 2026, buying an estimated $103K and bringing the position to 10,955 shares worth $5.94M. The position accounts for 0.95% of the portfolio, ranked #26.

Davidson Capital Management first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.39M in Q1 2026. 263 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Davidson Capital Management held 10,955 shares of United Therapeutics worth $5.94M as of Q2 2026.
  • Davidson Capital Management bought 182 United Therapeutics shares in Q2 2026, an estimated $103K.
  • United Therapeutics made up 0.95% of Davidson Capital Management's portfolio in Q2 2026, its #26 holding.
  • Davidson Capital Management first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Davidson Capital Management's United Therapeutics position peaked at $6.39M in Q1 2026.
  • 263 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Davidson Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.